Stay updated with breaking news from Pharma Major. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
43 companies are set to announce Q4 results, with Dr Reddy's and PB Fintech in focus. Dr Reddy's eyes revenue and net profit growth, while PB Fintech anticipates 18% YoY growth in core business premium.
According to an average estimate of four brokerages, revenue from operations in the January-March 2023 period is seen growing up to 18% year-on-year. Meanwhile, net profit after tax is likely to surge up to 54% YoY.
Nifty started higher but soon started losing altitude. It closed with a loss.
In May this year, Sun Pharmaceutical Industries announced a non-binding indication of interest to acquire all of the outstanding ordinary shares of Taro for a purchase price of USD 38 per ordinary share in cash through a reverse triangular merger.
India Business News: Natco Pharma, a pharmaceutical company based in Hyderabad, has reported a significant increase in its consolidated net profit for the second quarter o